Medirom Healthcare Releases Preliminary 2024 Financials
Ticker: MRM · Form: 6-K · Filed: Feb 18, 2025 · CIK: 1819704
Sentiment: neutral
Topics: financial-results, preliminary-results, 6-K
TL;DR
Medirom dropped preliminary 2024 results, check 'em out.
AI Summary
Medirom Healthcare Technologies Inc. filed a Form 6-K on February 18, 2025, to announce its unaudited, preliminary financial results for the year ended December 31, 2024. The filing includes a press release detailing these preliminary financial outcomes.
Why It Matters
This filing provides investors with an early look at Medirom's financial performance for the past fiscal year, allowing for timely assessment of the company's trajectory.
Risk Assessment
Risk Level: low — This is a routine filing to report preliminary financial results and does not contain significant new risks.
Key Players & Entities
- Medirom Healthcare Technologies Inc. (company) — Registrant
- February 18, 2025 (date) — Filing and press release date
- December 31, 2024 (date) — Reporting period end date
FAQ
What type of financial information is being released by Medirom Healthcare Technologies Inc.?
Medirom Healthcare Technologies Inc. is releasing unaudited, preliminary financial results for the year ended December 31, 2024.
When was this Form 6-K filed with the SEC?
This Form 6-K was filed on February 18, 2025.
What is the primary purpose of this Form 6-K filing?
The primary purpose is to announce certain unaudited, preliminary financial results for the year ended December 31, 2024, via an accompanying press release.
Does Medirom Healthcare Technologies Inc. file annual reports under Form 20-F or 40-F?
Medirom Healthcare Technologies Inc. files annual reports under Form 20-F.
What is the principal executive office address for Medirom Healthcare Technologies Inc.?
The principal executive office is located at 2-3-1 Daiba, Minato-ku, Tokyo 135-0091, Japan.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on February 18, 2025 regarding Medirom Healthcare Technologies Inc. (MRM).